Understanding Test Results
Cytology Codes
& management
Colposcopy- Management of cervical lesions
Cytology codes
 0/G-?Glandular neoplasia (non cervical)
 1-Inadequate Specimen
 2/N-Negative
 3/M-Low grade dyskaryosis (CIN 1)
 4-High grade dyskaryosis (severe) (CIN 3)
 5-High grade dyskaryosis ?invasive squamous carcinoma
 6-?Glandular neoplasia of endocervical type
 7-High grade dyskaryosis (moderate) (CIN 2)
 8/B-Borderline change in squamous cells
 9/E-Borderline change in endocervical cells
 X-No Cytology test undertaken
Action Codes
 A-To be used for all cases where the next test is to be
performed at the normal (routine) recall interval for the DHA
responsible for the women.
 R-To be used for all cases in which a further smear is
recommended in an interval less than the routine recall interval
of the DHA.
 S-To be used for all cases where referral to a gynaecologist is
recommended and for those smears from patients under the
care of a gynaecologist or other relevant specialist.
 H-Record the result and do not change current recall details.
Cytology Infection Code Descriptions
 0-Human Papilloma Virus (HPV) negative
 1-Trichomonas
 2-Candida
 3-Wartvirus
 4-Herpes
 5-Actinomyces
 6-Other (to be specified)
 9-HPV positive
 U-HPV unavailable
 Q-No HPV test undertaken
Examples
 N0A
1R3
4S
Guidelines for referral to the Colposcopy Clinic
Barts Health NHS Trust
Inadequate on 3 occasions
Borderline or mild dyskaryosis and high
risk HPV positive
Moderate or severe dyskaryosis
? Invasive or ? Glandular neoplasia
3 abnormal results over 10 years
Clinically suspicious cervix or symptoms
When referring women for colposcopy all women
should have explained to them:
The procedure of colposcopy
The possibility of a cervical biopsy
The Colposcope
 This is a binocular
microscope that allows
magnification and
illumination of the
cervix.
The Colposcopy Examination
 Acetic acid 5% is applied.
 The abnormality is identified (aceto-white
change).
 The colposcopic examination is considered
satisfactory when the entire transformation
zone has been identified, and a colposcopic
impression is made. A photograph may be
taken for accurate follow up.
 One or more biopsies are then taken of the
abnormal areas.
How Acetic acid works
 Acetic acid is applied to the surface of the cervix. The light from
the colposcope is reflected back from the enlarged nuclei of the
abnomal cells giving us the aceto-white change
Cervical punch biopsy forceps
Cervical Biopsies
Satisfactory Colposcopy
Unsatisfactory Colposcopy
Postmenopausal Cervix
Nabothian Cyst
Cervical Ectropion
Endocervical Polyp
HPV infection of the cervix
 Colposcopic Features
 Pale staining aceto-white lesion
 Irregular, indistinct margins of lesion
 Atypical vessels, fine mosaic pattern
HPV
Transmitted by intimate contact
An estimated 80% of sexually active
women will be exposed to the virus by
age 50
Most infections will regress
spontaneously after 6-12 months
Over time persistent infection can lead
to cancer and other HPV related
diseases
CIN1
 Mild aceto-white
uptake
 Irregular,
indistinct margins
of lesion
 No obvious atypical
vessels/mosaic
pattern
 In most women, will
revert back to
normal given time.
 Approximately 5%
of all smears show
borderline or mild
dyskaryosis.
CIN2
 Moderately
dense aceto-
white change
with atypical
vessels, mosaic
patterns
and punctation.
 Approximately
1% of all smears
show moderate
dyskaryosis.
CIN3
 Densely staining aceto-
white lesion
 Straight margins
 Atypical vessels, coarse
mosaicism, punctation
 Large volume lesion
 Poor iodine uptake
 Approximately 0.5% of
all smears show severe
dyskaryosis.
Micro-invasive lesions of the cervix
 Densely staining
acetowhite lesion
 Atypical vessels,
suspicious of invasion
 Often large volume
lesions
 Poor iodine uptake
 May bleed easily
 Less than 0.1% of
smears suggest invasive
carcinoma.
Treatment – LLETZ (Large Loop Excision of
the Transformation Zone)
 A diathermy pad is placed on the woman’s leg.
 Local anaesthesia is injected into the four quadrants
of the cervix. An appropriately sized loop is chosen
and the abnormal area removed in one piece under
colposcopic guidance. Ball diathermy is used to
achieve haemostasis.
 Facilities are available in the clinic in the event of an
emergency situation.
 Follow up information is reinforced before the woman
leaves the clinic.
LLETZ
What are the complications?
Treatment for CIN is generally very safe. Very few complications
exist but some important problems can occur.
1. Bleeding.
2. Infection.
3. Cervical stenosis’ and ‘cervical incompetence’
4. Premature rupture of membranes during pregnancy leading to early
delivery
Women are advised not to insert ANYTHING into the vagina for at least 4
weeks.
What is the success rate?
 Ninety five percent of women have a negative
smear 6 months following their first
treatment.
Follow-up
 A follow-up check after treatment for
precancerous changes is absolutely essential.
 We perform Liquid Based Cytology and HPV
testing six months after treatment.
 If residual precancerous cells are left
behind, further Colposcopy and biopsy is
performed, and a repeat LLETZ procedure,
will be arranged if necessary.
Changes to practice
 HPV testing
- TRIAGE
Given that cervical cancer will not develop without
HPV, women with borderline changes or mild
dyskaryosis who have a negative high risk HPV test
are not likely to need treatment and should be able to
safely return to routine screening.
- TEST OF CURE
It has now been clearly established that the
successful removal of abnormal cervical cells usually
also leads to the disappearance of the HPV within 12
months or so.
Further Information
www.bsccp.org.uk
www.jotrust.co.uk
www.patient.co.uk
www.cancerscreening.nhs.uk
www.londonqarc.nhs.uk

More Related Content

PPTX
Premalignant diseases of the cervix
PPTX
Cervical neoplasia 2021
PPT
Taking A Pap Smear
PDF
pap smear and cervical cytology for CIN & Cancers.pdf
PDF
Management of ovarian masses e Clinical situations & recommendations
PPTX
Cervical cancer
PDF
BENIGN & MALIGNANT CERVICAL DISEASE (1).pdf
PPT
Gynecology 5th year, 10th lecture (Dr. Hanaa)
Premalignant diseases of the cervix
Cervical neoplasia 2021
Taking A Pap Smear
pap smear and cervical cytology for CIN & Cancers.pdf
Management of ovarian masses e Clinical situations & recommendations
Cervical cancer
BENIGN & MALIGNANT CERVICAL DISEASE (1).pdf
Gynecology 5th year, 10th lecture (Dr. Hanaa)

Similar to understandingtestresutsbbhvvhhgddghvgAP.ppt (20)

PPT
Abnormal Pap Test
PPT
PAP test methods
PPTX
CERVICAL CANCER (CIN).pptx
PPT
Cin&cancer cervix undergraduate
PPTX
Cervicalcancer 180428125921-converted - copy final
PPTX
Cervical cancer screening 14.02.24.....pptx
PPT
screening_and_prevention protocols for_cervix.ppt
PPTX
Cervical cancer screening 14.02.24.....pptx
PPTX
Ovarian cancer .pptx
PPTX
Ovarian cancer .pptx
PPTX
Cervical cancer screening modalities
PPTX
Asccp management guidelines august 2014 ppt. Dr. Sharda Jain /Dr Jyoti Agarw...
PPT
Cervical canser screening.ppt
PDF
Chapter 2.4 cancer screening
PPTX
Cancer ovarian .pptx
PPTX
preinvasive lesion of cervix and management ,quick revise tool
PPTX
postmenopausal vaginal bleeding approach.pptx
PDF
Colposcopy case studies2
PPTX
4. Cellular Aberration
PPTX
Epithelial Ovarian carcinoma and role of laparoscopy in EOC
Abnormal Pap Test
PAP test methods
CERVICAL CANCER (CIN).pptx
Cin&cancer cervix undergraduate
Cervicalcancer 180428125921-converted - copy final
Cervical cancer screening 14.02.24.....pptx
screening_and_prevention protocols for_cervix.ppt
Cervical cancer screening 14.02.24.....pptx
Ovarian cancer .pptx
Ovarian cancer .pptx
Cervical cancer screening modalities
Asccp management guidelines august 2014 ppt. Dr. Sharda Jain /Dr Jyoti Agarw...
Cervical canser screening.ppt
Chapter 2.4 cancer screening
Cancer ovarian .pptx
preinvasive lesion of cervix and management ,quick revise tool
postmenopausal vaginal bleeding approach.pptx
Colposcopy case studies2
4. Cellular Aberration
Epithelial Ovarian carcinoma and role of laparoscopy in EOC
Ad

Recently uploaded (20)

DOCX
PT10 continues to explose your mind right after reading
PPTX
Tracheostomy Care: A Comprehensive Guide
PDF
Fundamentals Final Review Questions.docx.pdf
PPTX
OccupationalhealthPPT1Phealthinindustriesandsafety.pptx
PPTX
National immunization program_20250819_083950_0000.pptx
PPTX
FOOD IN RELATION TO NUTRITION AND HEALTH
PPTX
1. FAMILY PLANNING-1-2, nursing students
PDF
crisisintervention-210721062718.presetationdf
PPTX
osteoporosis in menopause...............
PPTX
Carcinoma of the breastfgdvfgbddbdtr.pptx
PPTX
Wound care MNEMONICS MNEMONICS health care
PDF
Zuri Health Pan-African Digital Health Innovator.pdf
PPTX
USG and its uses in anaesthesia practice
PDF
demography and familyplanning-181222172149.pdf
PPT
DENGUE_FEVER_&_DHF.pptfffffffffhffffffffffff
PPTX
Mortality rate in a teritiary care center of infia july stats sncu picu
PPTX
Foundations of Toxicology: Understanding Harmful Effects on Life and Environment
PPT
12.08.2025 Dr. Amrita Ghosh_Stocks Standards_ Smart_Inventory Management_GCLP...
PPT
Perioperative Nursing Care 1st bsc nursing.ppt
PDF
Medical_Biology_and_Genetics_Current_Studies_I.pdf
PT10 continues to explose your mind right after reading
Tracheostomy Care: A Comprehensive Guide
Fundamentals Final Review Questions.docx.pdf
OccupationalhealthPPT1Phealthinindustriesandsafety.pptx
National immunization program_20250819_083950_0000.pptx
FOOD IN RELATION TO NUTRITION AND HEALTH
1. FAMILY PLANNING-1-2, nursing students
crisisintervention-210721062718.presetationdf
osteoporosis in menopause...............
Carcinoma of the breastfgdvfgbddbdtr.pptx
Wound care MNEMONICS MNEMONICS health care
Zuri Health Pan-African Digital Health Innovator.pdf
USG and its uses in anaesthesia practice
demography and familyplanning-181222172149.pdf
DENGUE_FEVER_&_DHF.pptfffffffffhffffffffffff
Mortality rate in a teritiary care center of infia july stats sncu picu
Foundations of Toxicology: Understanding Harmful Effects on Life and Environment
12.08.2025 Dr. Amrita Ghosh_Stocks Standards_ Smart_Inventory Management_GCLP...
Perioperative Nursing Care 1st bsc nursing.ppt
Medical_Biology_and_Genetics_Current_Studies_I.pdf
Ad

understandingtestresutsbbhvvhhgddghvgAP.ppt

  • 2. Cytology Codes & management Colposcopy- Management of cervical lesions
  • 3. Cytology codes  0/G-?Glandular neoplasia (non cervical)  1-Inadequate Specimen  2/N-Negative  3/M-Low grade dyskaryosis (CIN 1)  4-High grade dyskaryosis (severe) (CIN 3)  5-High grade dyskaryosis ?invasive squamous carcinoma  6-?Glandular neoplasia of endocervical type  7-High grade dyskaryosis (moderate) (CIN 2)  8/B-Borderline change in squamous cells  9/E-Borderline change in endocervical cells  X-No Cytology test undertaken
  • 4. Action Codes  A-To be used for all cases where the next test is to be performed at the normal (routine) recall interval for the DHA responsible for the women.  R-To be used for all cases in which a further smear is recommended in an interval less than the routine recall interval of the DHA.  S-To be used for all cases where referral to a gynaecologist is recommended and for those smears from patients under the care of a gynaecologist or other relevant specialist.  H-Record the result and do not change current recall details.
  • 5. Cytology Infection Code Descriptions  0-Human Papilloma Virus (HPV) negative  1-Trichomonas  2-Candida  3-Wartvirus  4-Herpes  5-Actinomyces  6-Other (to be specified)  9-HPV positive  U-HPV unavailable  Q-No HPV test undertaken
  • 7. Guidelines for referral to the Colposcopy Clinic Barts Health NHS Trust Inadequate on 3 occasions Borderline or mild dyskaryosis and high risk HPV positive Moderate or severe dyskaryosis ? Invasive or ? Glandular neoplasia 3 abnormal results over 10 years Clinically suspicious cervix or symptoms
  • 8. When referring women for colposcopy all women should have explained to them: The procedure of colposcopy The possibility of a cervical biopsy
  • 9. The Colposcope  This is a binocular microscope that allows magnification and illumination of the cervix.
  • 10. The Colposcopy Examination  Acetic acid 5% is applied.  The abnormality is identified (aceto-white change).  The colposcopic examination is considered satisfactory when the entire transformation zone has been identified, and a colposcopic impression is made. A photograph may be taken for accurate follow up.  One or more biopsies are then taken of the abnormal areas.
  • 11. How Acetic acid works  Acetic acid is applied to the surface of the cervix. The light from the colposcope is reflected back from the enlarged nuclei of the abnomal cells giving us the aceto-white change
  • 20. HPV infection of the cervix  Colposcopic Features  Pale staining aceto-white lesion  Irregular, indistinct margins of lesion  Atypical vessels, fine mosaic pattern
  • 21. HPV Transmitted by intimate contact An estimated 80% of sexually active women will be exposed to the virus by age 50 Most infections will regress spontaneously after 6-12 months Over time persistent infection can lead to cancer and other HPV related diseases
  • 22. CIN1  Mild aceto-white uptake  Irregular, indistinct margins of lesion  No obvious atypical vessels/mosaic pattern  In most women, will revert back to normal given time.  Approximately 5% of all smears show borderline or mild dyskaryosis.
  • 23. CIN2  Moderately dense aceto- white change with atypical vessels, mosaic patterns and punctation.  Approximately 1% of all smears show moderate dyskaryosis.
  • 24. CIN3  Densely staining aceto- white lesion  Straight margins  Atypical vessels, coarse mosaicism, punctation  Large volume lesion  Poor iodine uptake  Approximately 0.5% of all smears show severe dyskaryosis.
  • 25. Micro-invasive lesions of the cervix  Densely staining acetowhite lesion  Atypical vessels, suspicious of invasion  Often large volume lesions  Poor iodine uptake  May bleed easily  Less than 0.1% of smears suggest invasive carcinoma.
  • 26. Treatment – LLETZ (Large Loop Excision of the Transformation Zone)  A diathermy pad is placed on the woman’s leg.  Local anaesthesia is injected into the four quadrants of the cervix. An appropriately sized loop is chosen and the abnormal area removed in one piece under colposcopic guidance. Ball diathermy is used to achieve haemostasis.  Facilities are available in the clinic in the event of an emergency situation.  Follow up information is reinforced before the woman leaves the clinic.
  • 27. LLETZ
  • 28. What are the complications? Treatment for CIN is generally very safe. Very few complications exist but some important problems can occur. 1. Bleeding. 2. Infection. 3. Cervical stenosis’ and ‘cervical incompetence’ 4. Premature rupture of membranes during pregnancy leading to early delivery Women are advised not to insert ANYTHING into the vagina for at least 4 weeks.
  • 29. What is the success rate?  Ninety five percent of women have a negative smear 6 months following their first treatment.
  • 30. Follow-up  A follow-up check after treatment for precancerous changes is absolutely essential.  We perform Liquid Based Cytology and HPV testing six months after treatment.  If residual precancerous cells are left behind, further Colposcopy and biopsy is performed, and a repeat LLETZ procedure, will be arranged if necessary.
  • 31. Changes to practice  HPV testing - TRIAGE Given that cervical cancer will not develop without HPV, women with borderline changes or mild dyskaryosis who have a negative high risk HPV test are not likely to need treatment and should be able to safely return to routine screening. - TEST OF CURE It has now been clearly established that the successful removal of abnormal cervical cells usually also leads to the disappearance of the HPV within 12 months or so.